Venture Partner
ElaiaCheck size: Elaia runs multiple strategies and does not publish one standard check-size range across all funds.
David Sourdive invests through Elaia's published strategy: Identify and scale IP-driven European ventures across digital technology, deep tech and life sciences through specialist investment teams and operating support.
Technically exceptional founders solving complex scientific or engineering problems with defensible intellectual property and global ambition.
Companies without meaningful technology or IP differentiation, or without fit to one of Elaia's specialist strategies, are less aligned.
Match the company to the relevant strategy and show the scientific or software edge, validation, commercialization path, team depth and capital milestones.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
David Sourdive is listed by Elaia as Venture Partner on the firm's current official roster. No employment history or personal investment preferences are inferred beyond the official title and firm-level strategy.